DK1513832T3 - Indol, azaindol og relaterede heterocykliske 4-alkenylpiperidinamider - Google Patents

Indol, azaindol og relaterede heterocykliske 4-alkenylpiperidinamider

Info

Publication number
DK1513832T3
DK1513832T3 DK03811179.5T DK03811179T DK1513832T3 DK 1513832 T3 DK1513832 T3 DK 1513832T3 DK 03811179 T DK03811179 T DK 03811179T DK 1513832 T3 DK1513832 T3 DK 1513832T3
Authority
DK
Denmark
Prior art keywords
alkenylpiperidinamides
azaindole
indole
related heterocyclic
heterocyclic
Prior art date
Application number
DK03811179.5T
Other languages
Danish (da)
English (en)
Inventor
Tao Wang
John F Kadow
Nicholas A Meanwell
Kap-Sun Yeung
Zhongxing Zhang
Zhilei Qiu
Daniel H Deon
Clint A James
Edward H Ruediger
Carol Bachand
Zhiwei Yin
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32312411&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1513832(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Application granted granted Critical
Publication of DK1513832T3 publication Critical patent/DK1513832T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK03811179.5T 2002-05-28 2003-04-30 Indol, azaindol og relaterede heterocykliske 4-alkenylpiperidinamider DK1513832T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US38350902P 2002-05-28 2002-05-28
PCT/US2003/013324 WO2004043337A2 (en) 2002-05-28 2003-04-30 Indole, azaindole and related heterocyclic 4-alkenyl piperidine amides

Publications (1)

Publication Number Publication Date
DK1513832T3 true DK1513832T3 (da) 2014-05-26

Family

ID=32312411

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03811179.5T DK1513832T3 (da) 2002-05-28 2003-04-30 Indol, azaindol og relaterede heterocykliske 4-alkenylpiperidinamider

Country Status (31)

Country Link
US (1) US20040063744A1 (enExample)
EP (1) EP1513832B1 (enExample)
JP (1) JP4446889B2 (enExample)
KR (1) KR101001811B1 (enExample)
CN (1) CN100528866C (enExample)
AR (1) AR040230A1 (enExample)
AU (1) AU2003301958B2 (enExample)
BR (2) BR0311541A (enExample)
CA (1) CA2487542C (enExample)
CL (1) CL2003001087A1 (enExample)
CO (1) CO5631440A2 (enExample)
DK (1) DK1513832T3 (enExample)
ES (1) ES2460728T3 (enExample)
GE (1) GEP20074152B (enExample)
HR (1) HRP20041137B1 (enExample)
IL (1) IL165200A (enExample)
IS (1) IS2945B (enExample)
MX (1) MXPA04011670A (enExample)
MY (1) MY139058A (enExample)
NO (1) NO329691B1 (enExample)
NZ (1) NZ536661A (enExample)
PE (1) PE20040526A1 (enExample)
PL (1) PL216388B1 (enExample)
PT (1) PT1513832E (enExample)
RS (1) RS53021B (enExample)
RU (1) RU2323934C2 (enExample)
SI (1) SI1513832T1 (enExample)
TW (1) TWI310381B (enExample)
UA (1) UA79470C2 (enExample)
WO (1) WO2004043337A2 (enExample)
ZA (1) ZA200409504B (enExample)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6476034B2 (en) * 2000-02-22 2002-11-05 Bristol-Myers Squibb Company Antiviral azaindole derivatives
US20040110785A1 (en) * 2001-02-02 2004-06-10 Tao Wang Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives
US20050075364A1 (en) * 2003-07-01 2005-04-07 Kap-Sun Yeung Indole, azaindole and related heterocyclic N-substituted piperazine derivatives
US20050124623A1 (en) 2003-11-26 2005-06-09 Bender John A. Diazaindole-dicarbonyl-piperazinyl antiviral agents
US7087610B2 (en) * 2004-06-03 2006-08-08 Bristol-Myers Squibb Company Benzothiazole antiviral agents
EP1753764B1 (en) 2004-06-09 2008-10-29 Glaxo Group Limited Pyrrolopyridine derivatives
US20060100432A1 (en) * 2004-11-09 2006-05-11 Matiskella John D Crystalline materials of 1-(4-benzoyl-piperazin-1-yl)-2-[4-methoxy-7-(3-methyl-[1,2,4]triazol-1-yl)-1H-pyrrolo[2,3-c]pyridin-3-yl]-ethane-1,2-dione
US20060100209A1 (en) * 2004-11-09 2006-05-11 Chong-Hui Gu Formulations of 1-(4-benzoyl-piperazin-1-yl)-2-[4-methoxy-7-(3-methyl-[1,2,4]triazol-1-yl)-1H-pyrrolo[2,3-c]pyridin-3-yl]-ethane-1,2-dione
US7601715B2 (en) * 2005-06-22 2009-10-13 Bristol-Myers Squibb Company Process for preparing triazole substituted azaindoleoxoacetic piperazine derivatives and novel salt forms produced therein
CA2618165A1 (en) * 2005-08-09 2007-02-15 Glaxo Group Limited Imidazopyridine derivatives as cannabinoid receptor ligands
US7851476B2 (en) * 2005-12-14 2010-12-14 Bristol-Myers Squibb Company Crystalline forms of 1-benzoyl-4-[2-[4-methoxy-7-(3-methyl-1H-1,2,4-triazol-1-YL)-1-[(phosphonooxy)methyl]-1H-pyrrolo[2,3-C]pyridin-3-YL]-1,2-dioxoethyl]-piperazine
US7807671B2 (en) * 2006-04-25 2010-10-05 Bristol-Myers Squibb Company Diketo-piperazine and piperidine derivatives as antiviral agents
US7504399B2 (en) * 2006-06-08 2009-03-17 Bristol-Meyers Squibb Company Piperazine enamines as antiviral agents
US7572810B2 (en) * 2006-06-08 2009-08-11 Bristol-Myers Squibb Company Alkene piperidine derivatives as antiviral agents
TWI443090B (zh) * 2007-05-25 2014-07-01 Abbvie Deutschland 作為代謝性麩胺酸受體２（ｍｇｌｕ２ 受體）之正向調節劑之雜環化合物
WO2009011912A1 (en) * 2007-07-18 2009-01-22 Bristol-Myers Squibb Company A composition for treating hiv comprising virus-like particles
WO2009158394A1 (en) * 2008-06-25 2009-12-30 Bristol-Myers Squibb Company Diketo azolopiperidines and azolopiperazines as anti-hiv agents
CN102076686B (zh) * 2008-06-25 2013-03-06 百时美施贵宝公司 作为hiv附着抑制剂的二酮哌啶衍生物
ES2383149T3 (es) * 2008-09-04 2012-06-18 Bristol-Myers Squibb Company Composicion farmacéutica estable para la administración optimizada de un inhibidor de la unión del VIH
CN104856991A (zh) * 2009-02-27 2015-08-26 西佳技术公司 用于治疗和预防登革热病毒感染的噻吩并吡啶衍生物
ES2436566T3 (es) 2009-04-02 2014-01-03 Shionogi & Co., Ltd. Compuestos de acrilamida y utilización de los mismos
EP2308866A1 (de) 2009-10-09 2011-04-13 Bayer CropScience AG Phenylpyri(mi)dinylpyrazole und ihre Verwendung als Fungizide
US8450361B2 (en) * 2010-08-06 2013-05-28 Bristol-Myers Squibb Company Substituted indole and azaindole oxoacetyl piperazinamide derivatives
ES2585396T3 (es) 2010-12-02 2016-10-05 VIIV Healthcare UK (No.5) Limited Alquilamidas como inhibidores de la unión del VIH
EP2696937B1 (en) 2011-04-12 2017-05-17 VIIV Healthcare UK (No.5) Limited Thioamide, amidoxime and amidrazone derivatives as hiv attachment inhibitors
ES2616268T3 (es) 2011-08-29 2017-06-12 VIIV Healthcare UK (No.5) Limited Derivados condensados de diamina bicíclica como inhibidores de la unión de VIH
ES2609579T3 (es) 2011-08-29 2017-04-21 VIIV Healthcare UK (No.5) Limited Derivados espiro de diamina bicíclica como inhibidores de la unión del VIH
BR112014019289A8 (pt) * 2012-02-08 2017-07-11 Bristol Myers Squibb Co Métodos para a preparação do composto de prome-dicamento de piperazina inibidor da ligação do hiv
US9193725B2 (en) 2012-03-14 2015-11-24 Bristol-Meyers Squibb Company Cyclic hydrazine derivatives as HIV attachment inhibitors
ES2616492T3 (es) * 2012-08-09 2017-06-13 VIIV Healthcare UK (No.5) Limited Derivados de piperidina amida como inhibidores de la fijación del VIH
ES2616432T3 (es) * 2012-08-09 2017-06-13 VIIV Healthcare UK (No.5) Limited Derivados de alquenos tricíclicos como inhibidores de la unión del VIH
WO2017112576A1 (en) * 2015-12-21 2017-06-29 Dow Global Technologies Llc Methods for external base-free suzuki couplings
CN108059611A (zh) * 2018-01-22 2018-05-22 济南舜景医药科技有限公司 一种用于治疗心率不齐药物中间体的合成方法
CN109053575A (zh) * 2018-08-24 2018-12-21 遵义医学院 3-环丙基-1-甲基-1h-吡唑-4-甲醛的制备工艺

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5023265A (en) * 1990-06-01 1991-06-11 Schering Corporation Substituted 1-H-pyrrolopyridine-3-carboxamides
US5124327A (en) * 1991-09-06 1992-06-23 Merck & Co., Inc. HIV reverse transcriptase
US5424329A (en) * 1993-08-18 1995-06-13 Warner-Lambert Company Indole-2-carboxamides as inhibitors of cell adhesion
TW429256B (en) * 1995-12-27 2001-04-11 Janssen Pharmaceutica Nv 1-(1,2-disubstituted piperidinyl)-4-(benzimidazolyl- and imidazopyridinyl)-piperidine derivatives
TW548271B (en) * 1996-12-20 2003-08-21 Astra Pharma Inc Novel piperidine derivatives having an exocyclic double bond with analgesic effects
WO1998028292A1 (en) * 1996-12-23 1998-07-02 Smithkline Beecham Corporation Novel piperidine containing compounds
US6469006B1 (en) * 1999-06-15 2002-10-22 Bristol-Myers Squibb Company Antiviral indoleoxoacetyl piperazine derivatives
US20020061892A1 (en) * 2000-02-22 2002-05-23 Tao Wang Antiviral azaindole derivatives
US6476034B2 (en) * 2000-02-22 2002-11-05 Bristol-Myers Squibb Company Antiviral azaindole derivatives
US6573262B2 (en) * 2000-07-10 2003-06-03 Bristol-Myers Sqibb Company Composition and antiviral activity of substituted indoleoxoacetic piperazine derivatives

Also Published As

Publication number Publication date
AR040230A1 (es) 2005-03-23
CA2487542A1 (en) 2004-05-27
CO5631440A2 (es) 2006-04-28
RU2004138565A (ru) 2005-07-20
RS53021B (sr) 2014-04-30
SI1513832T1 (sl) 2014-04-30
AU2003301958B2 (en) 2009-10-01
PT1513832E (pt) 2014-05-22
HRP20041137B1 (hr) 2014-11-21
WO2004043337A2 (en) 2004-05-27
RU2323934C2 (ru) 2008-05-10
UA79470C2 (en) 2007-06-25
TWI310381B (en) 2009-06-01
CN100528866C (zh) 2009-08-19
WO2004043337A3 (en) 2004-11-11
JP2006507326A (ja) 2006-03-02
KR101001811B1 (ko) 2010-12-15
PL216388B1 (pl) 2014-03-31
TW200406397A (en) 2004-05-01
CL2003001087A1 (es) 2005-02-11
IS7546A (is) 2004-11-22
CA2487542C (en) 2011-09-27
BRPI0311541B1 (pt) 2018-04-24
IL165200A (en) 2011-01-31
PE20040526A1 (es) 2004-08-28
CN1671697A (zh) 2005-09-21
ES2460728T3 (es) 2014-05-14
IS2945B (is) 2016-05-15
EP1513832B1 (en) 2014-03-05
NO20045064L (no) 2005-02-23
RS101304A (sr) 2006-10-27
NO329691B1 (no) 2010-11-29
PL373603A1 (en) 2005-09-05
NZ536661A (en) 2007-12-21
KR20050013558A (ko) 2005-02-04
US20040063744A1 (en) 2004-04-01
JP4446889B2 (ja) 2010-04-07
BR0311541A (pt) 2006-06-06
EP1513832A4 (en) 2010-03-10
MY139058A (en) 2009-08-28
GEP20074152B (en) 2007-07-10
HRP20041137A2 (en) 2005-06-30
EP1513832A2 (en) 2005-03-16
AU2003301958A1 (en) 2004-06-03
IL165200A0 (en) 2005-12-18
MXPA04011670A (es) 2005-03-07
ZA200409504B (en) 2006-05-31

Similar Documents

Publication Publication Date Title
DK1513832T3 (da) Indol, azaindol og relaterede heterocykliske 4-alkenylpiperidinamider
ATE501118T1 (de) Substituierte indole
EP1474135A4 (en) INDOL, AZAINDOL AND RELATED HETEROCYCLIC PYRROLIDINE DERIVATIVES
ATE340792T1 (de) Substituierte indole als alpha-1 agonisten
ATE392206T1 (de) Indolderivate als beta-2 agonisten
ATE517888T1 (de) Indolylmaleimid-derivate
DK1465615T3 (da) Tricykliske bisenonderivater og fremgangsmåder til anvendelse heraf
AU2003236512A8 (en) Indole, azaindole and related heterocyclic sulfonylureido piperazine derivatives
DK1732892T3 (da) Tetrahydrocarbazoler og derivater
NO20055026D0 (no) Indolonacetamid-derivater, fremgangsmate for fremstilling og anvendelse av disse
ATE292115T1 (de) Indolderivate als cox-ii-inhibitoren
ATE402923T1 (de) 2,4-substituierte indole und deren verwendung als 5-ht6 modulatoren
DK1587788T3 (da) 2,7-substituerede indoler og anvendelsen deraf som 5-HT6-modulatorer
NO20015737L (no) Indol derivater
IL166404A0 (en) Indoline derivatives substituted in
PT1228041E (pt) Derivados de indol
IS8002A (is) Setið indólín og indól afleiður
IS2431B (is) Nýjar indólafleiður
DE60323130D1 (de) Indolderivaten
DE60334703D1 (de) Heterocyclische derivate
HK1060287A (en) Indole, azaindole and related heterocyclic amidopiperazine derivatives
ATE464290T1 (de) Indole mit antidiabetischer wirkung
TH101401B (th) อนุพันธ์ไดเอมีน
IS7390A (is) 5-Heteróarýl setin indól